Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05993325 |
| Consolidated Lead Sponsor | Cellid Co |
| Therapeutic Condition Cohort | Infectious Disease and Vaccines |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 4,000 participants (ESTIMATED) |
| Registered Start Date | 2023-11-27 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Dong-A University Hospital | Busan, South Korea | Open Hospital Dossier -> |
| Kyungpook National University Hospital | Daegu, South Korea | Open Hospital Dossier -> |
| Chungnam National University Hospital | Daejeon, South Korea | Open Hospital Dossier -> |
| Chonnam National University Hospital | Gwangju, South Korea | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.